Fuller & Thaler Asset Management’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-870,633
Closed -$44.4M 653
2024
Q4
$44.4M Buy
870,633
+102,111
+13% +$5.02M 0.17% 194
2024
Q3
$31.7M Buy
+768,522
New +$36.9M 0.12% 228
2024
Q2
Sell
-27
Closed -$1.28K 594
2024
Q1
$1.28K Sell
27
-240,522
-100% -$12.8M ﹤0.01% 535
2023
Q4
$15.6M Buy
240,549
+22,394
+10% +$1.35M 0.08% 234
2023
Q3
$14.3M Buy
+218,155
New +$13.7M 0.08% 214
2021
Q3
Sell
-84,291
Closed -$7.86M 553
2021
Q2
$7.86M Sell
84,291
-4,782
-5% -$464K 0.05% 241
2021
Q1
$9.53M Buy
+89,073
New +$9.24M 0.07% 220

Other funds holding NARI

Fuller & Thaler Asset Management's NARI Position: Q1 2025 in Review

Fuller & Thaler Asset Management sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 870,633 shares — an estimated $44.4M sold.

Fuller & Thaler Asset Management first reported a position in NARI in Q1 2021 and held it in 7 quarters. The position peaked at $44.4M in Q4 2024. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Fuller & Thaler Asset Management reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Fuller & Thaler Asset Management sold 870,633 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $44.4M.
  • Fuller & Thaler Asset Management first reported a position in Inari Medical, Inc. Common Stock in Q1 2021 and held it in 7 quarters.
  • Fuller & Thaler Asset Management's Inari Medical, Inc. Common Stock position peaked at $44.4M in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Fuller & Thaler Asset Management's 13F filing for Q1 2025, filed 13 May 2025.